Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Post-stabilisation announcement

25 Sep 2013 12:40

RNS Number : 8650O
UBS Limited
25 September 2013
 



Post-stabilisation announcement

 

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

 

DIRECT LINE INSURANCE GROUP PLC

Stabilisation Notice

 

 

 

UBS Limited (contact: Gareth McCartney ; telephone: 0044 20756 82227), in its capacity as Stabilisation Manager, hereby gives notice that no Stabilisation (within the meaning of the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager named in relation to the offer of the following securities.

 

The Securities:

Vendor:

Royal Bank of Scotland Group plc

Underlying shares:

Direct Line Insurance Group plc

ISIN:

GB00B89W0M42

Base size:

272.7 million shares

Offer price:

210 pence

Maximum size of over-allotment facility:

10% of the aggregate nominal amount stated above

 

In connection with its Stabilisation activities, Royal Bank of Scotland Group plc granted UBS Limited, on behalf of the Underwriters, an over-allotment option, exercisable once for a period of 30 days after the announcement of the Offer Price on 20 September 2013 which, if exercised would require Royal Bank of Scotland Group plc to sell up to 10 per cent. of the aggregate number of Offering Shares available in the Offering (before any exercise of the Over-allotment Option) at the Offer Price to cover short positions arising from such over-allotments (if any) and/or sales of shares effected by it during the Stabilisation period.

 

UBS Limited agreed with Royal Bank of Scotland Group plc that any over-allotment of the Offering Shares by it or any of its agents will be up to a maximum of 10 per cent. of the total number of the Offering Shares (before any exercise of the Over-allotment Option).

 

Number of Offering Shares: 272.7 million

Number of shares subject to the over-allotment option: 27.3 million

 

No stabilisation trades have or will take place.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

The offer of the above securities and the distribution of this announcement and other information in connection with the offer of the above securities in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STANKPDNKBKDOCB
Date   Source Headline
30th Nov 20167:03 amRNSStatement re 2016 stress test results
22nd Nov 20163:35 pmRNSDividend Declaration
22nd Nov 20162:55 pmRNSPublication of Suppl.Prospcts
16th Nov 20166:00 pmRNSAllotment and Issue of New Ordinary Shares
9th Nov 20163:01 pmRNSDirector/PDMR Shareholding
8th Nov 20167:00 amRNSRBS Launches a New Complaints Process
31st Oct 20163:40 pmRNSTotal Voting Rights
28th Oct 20167:00 amRNSInterim Management Statement
6th Oct 20164:15 pmRNSBlock listing Interim Review
30th Sep 20161:37 pmRNSTotal Voting Rights
30th Sep 20167:00 amRNSProposed Future Ring Fenced Structure and Brands
28th Sep 20167:00 amRNSRBS Settles Certain RMBS Claims with the NCUA
27th Sep 20168:30 amRNSBank of America Merrill Lynch CEO Conference
12th Sep 20162:30 pmRNSBarclays Global Financial Services Conference
8th Sep 20167:00 amRNSRBSG priced $2.65 billion Senior Notes
2nd Sep 20165:44 pmRNSAllotment and Issue of new Ordinary shares
31st Aug 20162:43 pmRNSTotal Voting Rights
25th Aug 20167:02 amRNSDividend Declaration
25th Aug 20167:00 amRNSRedemption of USD Preference Shares Series R and T
23rd Aug 20163:00 pmRNSDirector/PDMR Shareholding
19th Aug 20162:15 pmRNSPublication of Suppl.Prospcts
11th Aug 20167:00 amRNSRBSG successfully priced $2.65bn Additional Tier
8th Aug 20163:30 pmRNSDirector/PDMR Shareholding
5th Aug 20167:00 amRNSHalf Year Report - Part 2
5th Aug 20167:00 amRNSHalf Year Report - Part 1
1st Aug 20167:07 amRNS2016 EBA EU-wide stress test results
29th Jul 20163:18 pmRNSTotal Voting Rights
21st Jul 20161:15 pmRNSVocaLink Holdings Limited Shareholding
30th Jun 20161:18 pmRNSTotal Voting Rights
29th Jun 20161:36 pmRNSHolding(s) in Company
27th Jun 20165:12 pmRNSDividend Declaration
24th Jun 201612:02 pmRNSPrice Monitoring Extension
9th Jun 20168:00 amRNSGoldman Sachs European Financials Conference
7th Jun 20165:30 pmRNSPublication of a Prospectus
1st Jun 20165:25 pmRNSNotification of Major Interest in Shares
31st May 20163:17 pmRNSTotal Voting Rights and Capital changes
26th May 20165:15 pmRNSDividend Declaration
24th May 20165:56 pmRNSAllotment and Issue of New Ordinary Shares
16th May 201610:00 amRNSAppointment of a Non-Executive Director
16th May 20167:07 amRNSNotices of Redemption
11th May 20163:39 pmRNSDirector/PDMR Shareholding
10th May 201612:40 pmRNSNotices of Redemption
4th May 20165:45 pmRNSResult of AGM
4th May 20161:55 pmRNSAGM Statement
29th Apr 20162:17 pmRNSTotal Voting Rights and Capital changes
29th Apr 20167:00 amRNSInterim Management Statement
28th Apr 20165:41 pmRNSRBS Holdings N.V. and Royal Bank of Scotland N.V.
28th Apr 20161:55 pmRNSUpdate on the disposal of Williams & Glyn
26th Apr 20164:04 pmRNSDividend Declaration
20th Apr 20163:03 pmRNSForm 8.3 - Electronic Data Processing plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.